Fremedica Technologies Inc. operates as a wholly possessed subsidiary of Frequency Exchange Corp. The corporation promotes a frequency transmitter that administers the advantages of bioresonance via a portable, wearable gadget. The Fremedica offering incorporates a specialized array of frequencies that bolster the immune system and hasten recuperation from Lyme ailment. Lyme represents the most rapidly expanding vector borne sickness in North America. Established in 2016, Fremedica has experienced swift expansion and presently caters to more than 1,000 clients.
Frequency Exchange
Headquarters
Canada